Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-H...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 144; no. 19; pp. 2063 - 2066
Main Authors Abro, Brooj, Maurer, Matthew J., Habermann, Thomas M., Burack, W. Richard, Chapman, Jennifer R., Cohen, Jonathon B., Friedberg, Jonathan W., Inghirami, Giorgio, Kahl, Brad S., Larson, Melissa C., Link, Brian K., Lossos, Izidore S., Martin, Peter, McDonnell, Timothy J., Nastoupil, Loretta J., Riska, Shaun M., Syrbu, Sergei, Vega, Francisco, Vij, Kiran R., Flowers, Christopher R., Cerhan, James R., Jaye, David L., Feldman, Andrew L.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.11.2024
Online AccessGet full text

Cover

More Information
Summary:Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-4971
1528-0020
1528-0020
DOI:10.1182/blood.2024025681